Australia markets closed

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
37.28-0.43 (-1.14%)
At close: 04:00PM EDT
37.10 -0.18 (-0.48%)
Pre-market: 08:05AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 76.61B
Enterprise value 94.89B
Trailing P/E 12.02
Forward P/E 9.75
PEG ratio (5-yr expected) 1.02
Price/sales (ttm)2.13
Price/book (mrq)4.91
Enterprise value/revenue 3.23
Enterprise value/EBITDA 10.27

Trading information

Stock price history

Beta (5Y monthly) 0.30
52-week change 326.54%
S&P500 52-week change 314.91%
52-week high 339.74
52-week low 328.78
50-day moving average 335.64
200-day moving average 335.43

Share statistics

Avg vol (3-month) 33.34M
Avg vol (10-day) 34.01M
Shares outstanding 52.05B
Implied shares outstanding 62.07B
Float 81.96B
% held by insiders 10.05%
% held by institutions 113.60%
Shares short (14 Sept 2023) 45.57M
Short ratio (14 Sept 2023) 41.56
Short % of float (14 Sept 2023) 4N/A
Short % of shares outstanding (14 Sept 2023) 40.27%
Shares short (prior month 14 Aug 2023) 45.26M

Dividends & splits

Forward annual dividend rate 41.4
Forward annual dividend yield 43.75%
Trailing annual dividend rate 30.56
Trailing annual dividend yield 31.47%
5-year average dividend yield 45.16
Payout ratio 446.22%
Dividend date 311 Oct 2023
Ex-dividend date 416 Aug 2023
Last split factor 21226:1000
Last split date 321 July 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 June 2023


Profit margin 52.60%
Operating margin (ttm)27.17%

Management effectiveness

Return on assets (ttm)6.71%
Return on equity (ttm)33.22%

Income statement

Revenue (ttm)29.33B
Revenue per share (ttm)14.52
Quarterly revenue growth (yoy)3.60%
Gross profit (ttm)19.92B
Net income avi to common (ttm)5.37B
Diluted EPS (ttm)3.10
Quarterly earnings growth (yoy)93.80%

Balance sheet

Total cash (mrq)6.5B
Total cash per share (mrq)3.21
Total debt (mrq)21.47B
Total debt/equity (mrq)176.61%
Current ratio (mrq)0.88
Book value per share (mrq)6.26

Cash flow statement

Operating cash flow (ttm)4.59B
Levered free cash flow (ttm)21.12B